BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 35969791)

  • 1. Small molecule photocatalysis enables drug target identification via energy transfer.
    Trowbridge AD; Seath CP; Rodriguez-Rivera FP; Li BX; Dul BE; Schwaid AG; Buksh BF; Geri JB; Oakley JV; Fadeyi OO; Oslund RC; Ryu KA; White C; Reyes-Robles T; Tawa P; Parker DL; MacMillan DWC
    Proc Natl Acad Sci U S A; 2022 Aug; 119(34):e2208077119. PubMed ID: 35969791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Target identification of natural and traditional medicines with quantitative chemical proteomics approaches.
    Wang J; Gao L; Lee YM; Kalesh KA; Ong YS; Lim J; Jee JE; Sun H; Lee SS; Hua ZC; Lin Q
    Pharmacol Ther; 2016 Jun; 162():10-22. PubMed ID: 26808165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chemical proteomics and discovery of drug targets].
    Yang HQ; Li XJ
    Yao Xue Xue Bao; 2011 Aug; 46(8):877-82. PubMed ID: 22007509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photochemical Methods Applied to DNA Encoded Library (DEL) Synthesis.
    Matsuo B; Granados A; Levitre G; Molander GA
    Acc Chem Res; 2023 Feb; 56(3):385-401. PubMed ID: 36656960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and validation nucleolin as a target of curcumol in nasopharyngeal carcinoma cells.
    Wang J; Wu J; Li X; Liu H; Qin J; Bai Z; Chi B; Chen X
    J Proteomics; 2018 Jun; 182():1-11. PubMed ID: 29684682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical proteomics: terra incognita for novel drug target profiling.
    Huang F; Zhang B; Zhou S; Zhao X; Bian C; Wei Y
    Chin J Cancer; 2012 Nov; 31(11):507-18. PubMed ID: 22640626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mass Spectrometry-Based Chemical Proteomics for Drug Target Discoveries.
    Fedorov II; Lineva VI; Tarasova IA; Gorshkov MV
    Biochemistry (Mosc); 2022 Sep; 87(9):983-994. PubMed ID: 36180990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical proteomics and its impact on the drug discovery process.
    Miao Q; Zhang CC; Kast J
    Expert Rev Proteomics; 2012 Jun; 9(3):281-91. PubMed ID: 22809207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Target identification for biologically active small molecules using chemical biology approaches.
    Lee H; Lee JW
    Arch Pharm Res; 2016 Sep; 39(9):1193-201. PubMed ID: 27387321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-O Bond Activation by Energy Transfer Photocatalysis.
    Lee DS; Soni VK; Cho EJ
    Acc Chem Res; 2022 Sep; 55(17):2526-2541. PubMed ID: 35986693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Target deconvolution of bioactive small molecules: the heart of chemical biology and drug discovery.
    Jung HJ; Kwon HJ
    Arch Pharm Res; 2015 Sep; 38(9):1627-41. PubMed ID: 26040984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The emerging role of mass spectrometry-based proteomics in drug discovery.
    Meissner F; Geddes-McAlister J; Mann M; Bantscheff M
    Nat Rev Drug Discov; 2022 Sep; 21(9):637-654. PubMed ID: 35351998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemical proteomics to identify molecular targets of small compounds.
    Sun B; He QY
    Curr Mol Med; 2013 Aug; 13(7):1175-91. PubMed ID: 23826922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploration of Visible-Light Photocatalysis in Heterocycle Synthesis and Functionalization: Reaction Design and Beyond.
    Chen JR; Hu XQ; Lu LQ; Xiao WJ
    Acc Chem Res; 2016 Sep; 49(9):1911-23. PubMed ID: 27551740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selecting targets for therapeutic validation through differential protein expression using chromatography-mass spectrometry.
    Patterson S
    Bioinformatics; 2002; 18 Suppl 2():S181. PubMed ID: 12386001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mass spectrometry-based clinical proteomics: head-and-neck cancer biomarkers and drug-targets discovery.
    Matta A; Ralhan R; DeSouza LV; Siu KW
    Mass Spectrom Rev; 2010; 29(6):945-61. PubMed ID: 20945361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and characterization of molecular targets of natural products by mass spectrometry.
    Cheng KW; Wong CC; Wang M; He QY; Chen F
    Mass Spectrom Rev; 2010; 29(1):126-55. PubMed ID: 19319922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Target identification with quantitative activity based protein profiling (ABPP).
    Chen X; Wong YK; Wang J; Zhang J; Lee YM; Shen HM; Lin Q; Hua ZC
    Proteomics; 2017 Feb; 17(3-4):. PubMed ID: 27723264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Recent advances in glycopeptide enrichment and mass spectrometry data interpretation approaches for glycoproteomics analyses].
    Liu L; Qin H; Ye M
    Se Pu; 2021 Oct; 39(10):1045-1054. PubMed ID: 34505426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.